O’Regan, Grace C.
Farag, Sahar H.
Ostroff, Gary R.
Tabrizi, Sarah J.
Andre, Ralph
Funding for this research was provided by:
Medical Research Council (MR/K501268/1, MR/L02053X/1)
Brain Research Trust
Rosetrees Trust (M220-F1)
Article History
Received: 28 February 2020
Accepted: 17 September 2020
First Online: 14 October 2020
Competing interests
: Through the offices of UCL Consultants Ltd, a wholly owned subsidiary of University College London, S.J.T. has undertaken consultancy services for Alnylam Pharmaceuticals Inc, Annexon Inc, DDF Discovery Ltd, F. Hoffmann-La Roche AG, Genentech Inc, GlaxoSmithKline plc, Novartis AG, Takeda Pharmaceuticals Ltd, Teva Pharmaceuticals Ltd, Triplet Theraputics Inc, UCB S.A., University College Irvine and Vertex Pharmaceuticals Inc. The other authors have no competing interests to declare.